Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and combination therapies is approaching magnitudes achieved with surgery. However, ...
Drugs like Ozempic and Wegovy may provide a surprising, life-saving benefit for the youngest patients taking these diabetes and weight loss medications.
In this study, adolescents with obesity prescribed a glucagon-like peptide 1 receptor agonists (GLP1R) had a lower incidence of ...
Wylie said: "Ozempic (semaglutide) is a medication licensed for the management of type 2 diabetes. While it has shown ...
Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD
Background Clinical studies have shown that glucagon-like peptide-1 receptor agonists (GLP-1 RA) can have beneficial effects ...
Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.
An online store has jumped on the Ozempic craze by releasing a “sexy” semaglutide injection costume just in time for ...
Men, baby boomers, and postgraduate-degree holders were among those most likely to say they wouldn’t choose medication over ...
The novel GLP-1 receptor agonists will likely reduce the need for CABG and improve surgical outcomes, several argue.
As prices for Ozempic have risen in recent months, many people may be seeking cheaper alternatives for managing diabetes or ...
Speakers from across the care continuum will discuss legislative updates, glucagon-like peptide-1 (GLP-1) use for weight management, and more at this year’s AMCP Nexus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback